• Filing Date: 2019-06-14
  • Form Type: 10-K
  • Description: Annual report
v3.19.2
RELATED PARTY TRANSACTIONS (Tables)
12 Months Ended
Mar. 31, 2019
Table Text Block Supplement [Abstract]  
Schedule of Related Party Transactions

Following is a summary of activity between the Company and Pharma, B&W and NDM for the years ended March 31, 2019, 2018 and 2017. These amounts are unsecured, interest free, and payable on demand.

 

             
   

Year Ended

March 31,

2019

($)

 

Year Ended

March 31,

2018

($)

 

Year Ended

March 31,

2017

($)

Balance due to Pharma and NDM at beginning of period     613,818       687,609       494,145  
Amounts received from Pharma     —         145,214       2,480  
Amounts invoiced by Pharma to DDL, NM and TCL (1)     2,312,412       842,739       577,481  
Amounts invoiced by DDL to Pharma     (977 )     —         (15,305 )
Amounts repaid by DDL to Pharma     (1,569,496 )     (1,096,767 )     (249,060 )
Amounts paid by DDL on behalf of Pharma     —         (19,889 )     (42,403 )
Amounts invoiced by B&W to DDL     2,206       —         —    
Amounts repaid by DDL to B&W     (5,622 )     —         —    
Foreign exchange differences     (84,843 )     54,912       (79,729 )
Forgiveness of payable accounted for as equity contribution     (302,819 )     —         —    
Net balance due to Pharma and NDM at end of the period     964,679       613,818       687,609  

 

  (1) These amounts are included primarily in research and development expenses.